UBS Group’s DiaMedica Therapeutics DMAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$32.2K Buy
8,266
+3,884
+89% +$15.1K ﹤0.01% 6804
2025
Q1
$16.6K Buy
4,382
+2,613
+148% +$9.9K ﹤0.01% 7044
2024
Q4
$9.61K Sell
1,769
-10,970
-86% -$59.6K ﹤0.01% 7112
2024
Q3
$53.4K Buy
+12,739
New +$53.4K ﹤0.01% 5578
2024
Q2
Sell
-1,926
Closed -$5.34K 8414
2024
Q1
$5.34K Buy
+1,926
New +$5.34K ﹤0.01% 6375
2023
Q4
Sell
-84
Closed -$217 8159
2023
Q3
$217 Buy
+84
New +$217 ﹤0.01% 7537
2023
Q2
Sell
-2,038
Closed -$3.12K 7925
2023
Q1
$3.12K Sell
2,038
-1,719
-46% -$2.63K ﹤0.01% 7279
2022
Q4
$5.94K Sell
3,757
-3,434
-48% -$5.43K ﹤0.01% 7910
2022
Q3
$9K Buy
7,191
+4,161
+137% +$5.21K ﹤0.01% 7464
2022
Q2
$6K Buy
3,030
+2,080
+219% +$4.12K ﹤0.01% 7621
2022
Q1
$2K Sell
950
-3,668
-79% -$7.72K ﹤0.01% 8559
2021
Q4
$17K Buy
+4,618
New +$17K ﹤0.01% 6935
2021
Q3
Sell
-20,715
Closed -$92K 8424
2021
Q2
$92K Buy
20,715
+19,665
+1,873% +$87.3K ﹤0.01% 4910
2021
Q1
$10K Buy
1,050
+136
+15% +$1.3K ﹤0.01% 6889
2020
Q4
$9K Buy
+914
New +$9K ﹤0.01% 6529
2020
Q3
Sell
-589
Closed -$4K 7132
2020
Q2
$4K Sell
589
-7,911
-93% -$53.7K ﹤0.01% 6581
2020
Q1
$24K Buy
+8,500
New +$24K ﹤0.01% 5468
2019
Q4
Sell
-2,354
Closed -$5K 7035
2019
Q3
$5K Buy
2,354
+104
+5% +$221 ﹤0.01% 6492
2019
Q2
$11K Buy
+2,250
New +$11K ﹤0.01% 6126
2019
Q1
Sell
-1,323
Closed -$4K 6898
2018
Q4
$4K Buy
+1,323
New +$4K ﹤0.01% 6689